Russell Investments Group, Ltd. Ac Immune Sa Transaction History

Russell Investments Group, Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$4.78 - $9.06 $12,676 - $24,027	-2,652 Closed	0 $0
Q1 2020 May 06, 2020	SELL	$4.24 - $9.89 $36,998 - $86,300	-8,726 Reduced 76.69%	2,652 $19,000
Q4 2019 Jan 29, 2020	BUY	$4.56 - $8.78 $51,883 - $99,898	11,378 New	11,378 $93,000
Q3 2019 Nov 01, 2019	SELL	$4.8 - $5.89 $6,835 - $8,387	-1,424 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$4.72 - $5.88 $6,721 - $8,373	1,424 New	1,424 $8,000

27.9M

150K

12.4K

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $218M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.